ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling (2019)

First Author: Bolado-Carrancio A

Attributed to: Precision medicine and the mutational landscape of high grade serous ovarian cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/767533

Publication URI: http://dx.doi.org/10.1101/767533

Type: Preprint